Investor · 1 deal
London
Every published round Marex Group took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Ruminant Biotech | Series A | Nov 2025 | $14.8m | Lead | Startup Daily, SmartCompany |
Companies Marex Group has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ruminant Biotech | Nov 2025, Series A | 1 | 1 |
Fund closes reported for Marex Group, as distinct from the investments it has made.
Companies Marex Group has backed that another company then bought. An exit for the holding, not a deal Marex Group did.
Stories naming Marex Group. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Funding roundup covering four raises: Pay.com.au's $25 million round plus a $28 million secondary, Ruminant Biotech's Series A, Australis Scientific's Rohto-backed funding, and Paperly's $3 million round led by Tribe Global Ventures.